Kaival Brands Expects Sales Boost for Bidi Stick Vapor Products After Court Ruling

Aug.30.2022
Kaival Brands Expects Sales Boost for Bidi Stick Vapor Products After Court Ruling
Kaival Brands, US distributor for Bidi Vapor, expects sales of their Bidi Stick vapor products to benefit from recent court rulings.

Kaival Brands, the U.S. distributor of products manufactured by Bidi Vapor, expects an increase in sales of their Bidi Stick vapor product following a recent court ruling in the United States. The U.S. Food and Drug Administration (FDA) will be revisiting the pre-market tobacco product application (PMTA) for the company.


On August 23rd, six companies, including Bidi Vapor and Diamond Vapor, filed a petition for review with the 11th Circuit Court of Appeals, questioning the FDA's rejection of their e-cigarette applications. According to Chief Judge William Pryor, the agency failed to properly evaluate these companies' marketing and sales access restriction plans aimed at minimizing youth exposure and access.


This ruling effectively overturns the order to cease marketing and allows Bidi Vapor to continue selling all flavor varieties of Bidi Stick in the United States. The company submitted PMTA for all 11 Bidi Stick flavors prior to September. The PMTA deadline was on September 9, 2020.


Eric Mosser, President and Chief Operating Officer of Kaival Brands, announced that the decision to become the exclusive distributor of Bidi Vapor products in the United States is a significant milestone for the company and its downstream partners. This decision paves the way for potential revenue growth and many have been eagerly awaiting the expansion of distribution.


But not only that, we are pleased that the appellate court recognizes the potential importance and direct impact of marketing programs focused on adults and strict sales and access restrictions in addressing youth access issues.


At the time of publication, the FDA had not announced how they will respond to the court ruling. The agency may appeal the decision or conduct a scientific review of Bidi Vapor's non-tobacco flavored devices' PMTA.


Statement:


This article is compiled from third-party information and is intended for industry discussion and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The translation of this article is intended solely for industry exchange and research purposes.


Due to the limited ability to translate, the translated article may not represent the original text accurately. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign-related expression and position.


The compiled information is copyrighted by the original media and authors. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Behind R.J Reynolds Tobacco's PACHA Acquisition: CHUC Pivots to Unregulated Hexamethyl Nicotine in Survival Bid
Behind R.J Reynolds Tobacco's PACHA Acquisition: CHUC Pivots to Unregulated Hexamethyl Nicotine in Survival Bid
Amid tightening U.S. e-cigarette regulations, Charlie’s Holdings (CHUC) has agreed to sell 12 PMTA-pending disposable e-cigarette products under its flagship PACHA brand to BAT-owned Reynolds Vapor Company in a deal worth up to $9.2 million. Concurrently, the company is pivoting to its "unregulated" Metatine (hexamethyl nicotine) product line, seeking to carve out a niche in regulatory gaps.
Apr.23 by 2FIRSTS.ai
BAT's 500 million euros Investment Plan in Spain Faces Regulatory Restrictions
BAT's 500 million euros Investment Plan in Spain Faces Regulatory Restrictions
BAT's investment plans in Spain face obstacles due to strict regulations impacting tobacco product factory establishment in Barcelona.
Apr.17 by 2FIRSTS.ai
Philippines DTI Reports $740K in Illegal E-Cigarette Seizures and Removal of 100 Million Violation Records This Year
Philippines DTI Reports $740K in Illegal E-Cigarette Seizures and Removal of 100 Million Violation Records This Year
Between January and May 2025, the Philippine DTI seized $740,000 worth of illegal e-cigarettes from 88 unauthorized brands. Over 104 million online violations were removed, 628 businesses flagged, 385 legal notices issued, and 10 brands suspended.
May.28
Argentine Lawmakers Call for Strict Enforcement of E-cigarette Ban
Argentine Lawmakers Call for Strict Enforcement of E-cigarette Ban
Lawmakers in Tucumán Province, Argentina, criticized the government for not enforcing the e-cigarette ban and called for action to protect public health and fulfill its commitment to the people.
Apr.29 by 2FIRSTS.ai
Malaysia Tightens E-Cigarette Regulations, Expands Enforcement to Ads, Packaging, and Sales
Malaysia Tightens E-Cigarette Regulations, Expands Enforcement to Ads, Packaging, and Sales
Malaysia’s Health Ministry has unveiled stricter e-cigarette regulations, covering registration, advertising, packaging, and display—aimed at protecting minors. The health minister noted the rules are dynamic and will be updated as new evidence arises. As for calls for a total ban, he said that falls under local government authority.
Apr.25 by 2FIRSTS.ai
U.S. Compliance Specialist: Why an STN Falls Short for NGPs Entering the U.S. Market
U.S. Compliance Specialist: Why an STN Falls Short for NGPs Entering the U.S. Market
Many manufacturers misunderstand the role of an STN in the U.S. regulatory framework. This article explains why only a fully approved PMTA ensures legal market access—and why stopping at the STN stage could carry significant risks.
May.09